Published in J Alzheimers Dis on January 01, 2010
Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology (2011) 0.96
Age-related differences in iron content of subcortical nuclei observed in vivo: a meta-analysis. Neuroimage (2012) 0.93
In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease. PLoS One (2013) 0.93
Iron and mechanisms of neurotoxicity. Int J Alzheimers Dis (2010) 0.91
Iron chelation and neuroprotection in neurodegenerative diseases. J Neural Transm (Vienna) (2010) 0.89
HFE gene variants, iron, and lipids: a novel connection in Alzheimer's disease. Front Pharmacol (2014) 0.81
Appraising the Role of Iron in Brain Aging and Cognition: Promises and Limitations of MRI Methods. Neuropsychol Rev (2015) 0.81
In Vivo MRI Mapping of Brain Iron Deposition across the Adult Lifespan. J Neurosci (2016) 0.80
Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis. BMC Med Genet (2012) 0.80
Neuroimaging, nutrition, and iron-related genes. Cell Mol Life Sci (2013) 0.80
Premenopausal hysterectomy is associated with increased brain ferritin iron. Neurobiol Aging (2011) 0.79
Iron uptake and transport across physiological barriers. Biometals (2016) 0.78
Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease. Metab Brain Dis (2012) 0.78
Effect modification by transferrin C2 polymorphism on lead exposure, hemoglobin levels, and IQ. Neurotoxicology (2013) 0.77
Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats. Mol Neurobiol (2016) 0.76
Reduced white matter MRI transverse relaxation rate in cognitively normal H63D-HFE human carriers and H67D-HFE mice. Brain Imaging Behav (2016) 0.75
Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals. Neuroimage Clin (2017) 0.75
Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci (2004) 5.37
Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol (2003) 5.00
The effect of age on the non-haemin iron in the human brain. J Neurochem (1958) 4.83
How can we learn about developmental processes from cross-sectional studies, or can we? Am J Psychiatry (2000) 2.70
Iron status and neural functioning. Annu Rev Nutr (2003) 2.63
Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord (2002) 2.56
Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology (2002) 2.52
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging (2004) 2.29
Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 2.23
A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology (2008) 2.21
Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging (2009) 2.14
Oligodendrocytes and myelination: the role of iron. Glia (2009) 1.90
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging (2006) 1.87
Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) (1992) 1.58
Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics (2008) 1.58
Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J Biol Chem (2008) 1.56
Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis (2010) 1.54
Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn Reson Med (1997) 1.46
Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J Alzheimers Dis (2009) 1.43
In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch Gen Psychiatry (2000) 1.41
Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med (1993) 1.37
Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA (2001) 1.33
MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging (1999) 1.31
T1 and T2 of ferritin solutions: effect of loading factor. Magn Reson Med (1996) 1.28
The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med (1996) 1.27
The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut (1998) 1.25
Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann N Y Acad Sci (2004) 1.23
Abnormal brain iron homeostasis in human and animal prion disorders. PLoS Pathog (2009) 1.22
In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol (1994) 1.21
Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences. J Neurol Sci (2004) 1.21
MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J Magn Reson Imaging (2009) 1.18
Relative importance of female-specific and non-female-specific effects on variation in iron stores between women. Br J Haematol (2003) 1.18
Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain (1999) 1.16
Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism. Neurosci Lett (2003) 1.13
Human brain myelination and amyloid beta deposition in Alzheimer's disease. Alzheimers Dement (2007) 1.10
MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Reson Imaging (1997) 1.08
Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus. Neurotox Res (2008) 1.07
In situ characterization and mapping of iron compounds in Alzheimer's disease tissue. J Alzheimers Dis (2005) 1.05
Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). J Alzheimers Dis (2008) 1.04
A novel approach to the identification and quantitative elemental analysis of amyloid deposits--insights into the pathology of Alzheimer's disease. Biochem Biophys Res Commun (2009) 1.02
Increased basal ganglia iron levels in Huntington disease. Arch Neurol (1999) 1.01
Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochim Biophys Acta (2008) 1.01
Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J Alzheimers Dis (2008) 1.00
Altered iron metabolism is part of the choroid plexus response to peripheral inflammation. Endocrinology (2009) 1.00
Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet (2000) 1.00
Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease. Biochem Soc Trans (2008) 0.99
The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration. J Magn Reson Imaging (1996) 0.95
Magnetic resonance imaging of brain iron in health and disease. J Neurol Sci (1995) 0.95
HFE mutations and Alzheimer's disease. J Alzheimers Dis (2006) 0.95
The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. Neurobiol Aging (2001) 0.91
Clinical report of three patients with hereditary hemochromatosis and movement disorders. Mov Disord (2000) 0.91
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators. FASEB J (2007) 0.90
Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE. Am J Med Genet B Neuropsychiatr Genet (2003) 0.90
Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. J Alzheimers Dis (2008) 0.89
Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease. Dement Geriatr Cogn Disord (2003) 0.89
Induction of iron homeostasis genes during estrogen-induced uterine growth and differentiation. Mol Cell Endocrinol (2006) 0.87
Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Leg Med (Tokyo) (2003) 0.85
Aspirin intake and the use of serum ferritin as a measure of iron status. Am J Clin Nutr (2001) 0.84
Iron genes, iron load and risk of Alzheimer's disease. J Med Genet (2006) 0.84
Analysis of the effect of aluminum in drinking water and transferrin C2 allele on Alzheimer's disease. Eur J Neurol (2006) 0.84
Iron chelation as a potential therapy for neurodegenerative disease. Biochem Soc Trans (2008) 0.83
Formation of amyloid-beta oligomers in brain vascular smooth muscle cells transiently exposed to iron-induced oxidative stress. Acta Neuropathol (2009) 0.81
Ferritin: the role of aluminum in ferritin function. Neurobiol Aging (1992) 0.81
The role of metal ions in oxidative processes and aging. Toxicol Ind Health (1993) 0.81
HFE variants, APOE and Alzheimer's disease: findings from the population-based Rotterdam study. Neurobiol Aging (2007) 0.80
Strong association of de novo copy number mutations with autism. Science (2007) 27.84
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature (2012) 13.61
Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet (2008) 12.18
Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A (2003) 10.56
Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature (2011) 10.16
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39
Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet (2008) 7.13
Functional organization of the transcriptome in human brain. Nat Neurosci (2008) 7.02
Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA (2006) 6.48
Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. AJR Am J Roentgenol (2006) 6.13
Conservation and evolution of gene coexpression networks in human and chimpanzee brains. Proc Natl Acad Sci U S A (2006) 5.69
Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron (2009) 5.46
Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet (2008) 5.44
Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci (2004) 5.37
Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry (2006) 5.30
A functional genetic link between distinct developmental language disorders. N Engl J Med (2008) 4.99
Elevated gene expression levels distinguish human from non-human primate brains. Proc Natl Acad Sci U S A (2003) 4.69
Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell (2011) 4.58
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry (2008) 4.02
FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains. Nat Neurosci (2006) 3.81
Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet (2008) 3.66
Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med (2011) 3.66
A unified genetic theory for sporadic and inherited autism. Proc Natl Acad Sci U S A (2007) 3.47
A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42
Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet (2009) 3.42
Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet (2007) 3.11
Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. Science (2004) 3.01
Self-gated cardiac cine MRI. Magn Reson Med (2004) 2.97
A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J Neurosci (2008) 2.97
PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry. Proc Natl Acad Sci U S A (2005) 2.93
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. J Neurosci (2004) 2.89
Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell (2013) 2.87
Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proc Natl Acad Sci U S A (2010) 2.85
Human-specific transcriptional networks in the brain. Neuron (2012) 2.80
Brief cognitive-behavioral therapy effects on post-treatment suicide attempts in a military sample: results of a randomized clinical trial with 2-year follow-up. Am J Psychiatry (2015) 2.80
The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone. Biol Psychiatry (2002) 2.70
Iron status and neural functioning. Annu Rev Nutr (2003) 2.63
Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet (2013) 2.62
Early asymmetry of gene transcription in embryonic human left and right cerebral cortex. Science (2005) 2.56
Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet (2007) 2.55
Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke (2009) 2.55
A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet (2003) 2.51
Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics (2008) 2.50
Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia. Am J Psychiatry (2011) 2.47
Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry (2007) 2.47
Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46
A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry (2007) 2.45
Transcriptional architecture of the primate neocortex. Neuron (2012) 2.42
Human brain evolution: insights from microarrays. Nat Rev Genet (2004) 2.42
Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain (2010) 2.41
The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice. Proc Natl Acad Sci U S A (2008) 2.37
Human-specific transcriptional regulation of CNS development genes by FOXP2. Nature (2009) 2.33
A diet-induced mouse model for glutaric aciduria type I. Brain (2006) 2.31
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry (2006) 2.29
Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum Genet (2001) 2.29
Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron (2002) 2.28
The poor prognosis of childhood-onset bipolar disorder. J Pediatr (2007) 2.26
Evidence for sex-specific risk alleles in autism spectrum disorder. Am J Hum Genet (2004) 2.24
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23
Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging (2004) 2.23
Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. J Consult Clin Psychol (2003) 2.20
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry (2008) 2.17
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14
Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics (2013) 2.11
Sex differences in autism spectrum disorders. Curr Opin Neurol (2013) 2.11
A quantitative trait locus analysis of social responsiveness in multiplex autism families. Am J Psychiatry (2007) 2.09
Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. Am J Hum Genet (2007) 2.08
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS One (2008) 2.08
An evaluation of tyramide signal amplification and archived fixed and frozen tissue in microarray gene expression analysis. Nucleic Acids Res (2002) 2.06
Identification of process-localized mRNAs from cultured rodent hippocampal neurons. J Neurosci (2006) 2.02
Persistent neurochemical and behavioral abnormalities in adulthood despite early iron supplementation for perinatal iron deficiency anemia in rats. Behav Brain Res (2006) 2.02
High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. Am J Hum Genet (2007) 2.01
Consistency of Brief Psychiatric Rating Scale factor structure across a broad spectrum of schizophrenia patients. Psychopathology (2007) 2.01
Persistent metabolic crisis as measured by elevated cerebral microdialysis lactate-pyruvate ratio predicts chronic frontal lobe brain atrophy after traumatic brain injury. Crit Care Med (2008) 2.00
Cardiac MR imaging: state of the technology. Radiology (2006) 2.00
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. J Neurosci Res (2008) 1.96
Strategies for aggregating gene expression data: the collapseRows R function. BMC Bioinformatics (2011) 1.96
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem (2005) 1.95
X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet (2008) 1.95
Evidence for deficient modulation of amygdala response by prefrontal cortex in bipolar mania. Psychiatry Res (2007) 1.93
White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol (2003) 1.93
Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry (2002) 1.93
Lifespan trajectory of myelin integrity and maximum motor speed. Neurobiol Aging (2008) 1.92
Oligodendrocytes and myelination: the role of iron. Glia (2009) 1.90